Gold rally "fundamentally supported for now," AHG President tells Investing.com
Douglas Murphy-Chutorian, CEO, interim CFO and Director of Semler Scientific, Inc. (NASDAQ:SMLR), sold 70,406 shares of common stock on November 17, 2025, for approximately $1.42 million. The sales occurred in multiple transactions with prices ranging from $19.57 to $21.26. This insider selling comes as Semler’s stock has fallen significantly, with a 26.8% decline in the past week and a 51% drop over the last six months, according to InvestingPro data.
According to a Form 4 filing with the Securities and Exchange Commission, the transactions also included the exercise of stock options for 125,000 shares at an exercise price of $2.23, totaling $278,750. Despite recent price declines, Semler maintains impressive gross profit margins of 90.76% and trades at a P/E ratio of 5.35, though InvestingPro analysis suggests the stock is currently slightly overvalued.
Additionally, Murphy-Chutorian disposed of 54,594 shares of Semler Scientific, Inc. common stock, and acquired the same amount via a family trust. The company, currently valued at approximately $326 million, remains profitable over the last twelve months but analysts anticipate a sales decline in the current year. InvestingPro offers 8 more investment tips and a comprehensive Pro Research Report on Semler Scientific, one of 1,400+ US equities covered with deep-dive analysis.
In other recent news, Semler Scientific has been actively involved in a pending merger with Strive, Inc. The company filed several supplemental disclosures with the Securities and Exchange Commission, providing unaudited pro forma combined consolidated financial information related to this all-stock transaction. This merger agreement, initially announced on September 22, 2025, is still subject to customary closing conditions. Additionally, Semler Scientific released preliminary financial information for the third quarter of 2025, projecting revenues between $6.9 million and $7.5 million, while operating expenses are estimated to range from $12.8 million to $13.4 million. The company also reported an unrealized gain of approximately $30.0 million from its Bitcoin holdings, which amounted to 5,048 Bitcoins valued at $575.8 million. In other developments, Semler Scientific updated its Bitcoin performance metrics, indicating a 0.9% yield for the third quarter and 30.6% year-to-date through November 10, 2025. The company maintains a dashboard on its website to provide public access to information regarding its Bitcoin holdings, fulfilling its disclosure obligations under Regulation FD. These recent developments provide investors with a comprehensive view of Semler Scientific’s current financial and strategic positioning.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.